Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Neurotrophic Bioscience Inc.

Latest From Neurotrophic Bioscience Inc.

Neurotrophic Bioscience Inc.

Despite setbacks by neuroscience companies Cephalon Inc. and Regeneron Pharmaceuticals Inc., the hope that neurotrophic factors will provide relief for millions of sufferers of neurodegenerative diseases, by slowing the progression of the disease, is alive and kicking. Neurotrophic Biosciences hopes to succeed where others have not by taking an approach that will apply combinations of highly specific neurotrophic factors, many of them newly discovered, to the treatment of neurodegenerative diseases.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Neurotrophic Bioscience Inc.
  • Senior Management
  • Anthony Giovinazzo, Pres. & CEO
    John Commissiong, PhD, CSO
  • Contact Info
  • Neurotrophic Bioscience Inc.
    Phone: (416) 674-8047
    96 Skyway Ave.
    Etobicoke, M9W 4Y9